Inactive Instrument

Highlights Bayer Aktiengesellschaft Other OTC

Equities

IQ-AI Unit Delivers Software to Insel Gruppe	May. 17	MT
Bayer: elinzanetant data presented at congress	May. 17	CF
Bayer’s Menopause Drug Reduces Hot Flashes in Late-stage Studies	May. 17	MT
Ag inputs sales seen at good level in the US, not as good in South America	May. 16	RE
Bayer to present new data at ASCO	May. 16	CF
Bayer Starts Phase I Study with Novel Targeted Radionuclide Therapy 225Ac-Psma-Trillium in Advanced Metastatic Prostate Cancer	May. 15	CI
Chemical industry sees first rays of hope and becomes more confident for 2024	May. 15	DP
Bayer Launches First-in-Human Study of Prostate Cancer Drug Candidate	May. 15	MT
BAYER : As soft as anticipated	May. 14
Global markets live: Apple, Sony, Vodafone, Booking, Walmart...	May. 14
Bayer Plans More Job Cuts in Push for Fewer Bosses -- Update	May. 14	DJ
Jefferies rates Bayer a 'Hold' - Target 29 euros	May. 14	DP
Deutsche Bank Research rates Bayer a 'Hold' - Target 29 euros	May. 14	DP
CAC40: little movement on the eve of US inflation	May. 14	CF
Bayer stagnates after good run - headwind from exchange rates	May. 14	DP
Bayer: core EPS down 4% in Q1	May. 14	CF
Bayer Net Profit Falls on Lower Sales, Currency Headwinds	May. 14	DJ
Bayer's first-quarter adjusted profit beats market view	May. 14	RE
German Drugmaker Bayer Posts Decline in Q1 Income, Net Sales	May. 14	MT
Bayer's Q1 adjusted profit beats analyst consensus	May. 14	RE

No results for this search

BAYER : As soft as anticipated

May 14, 2024 at 02:12 pm EDT

Bayer AG: Not out of the woods yet

March 06, 2024 at 10:46 am EST